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Pressure distention compared with pharmacologic
relaxation in vein grafting upregulates matrix
metalloproteinase-2 and -9
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Objective: Autogenous vein bypasses are a common and effective method to treat occlusive disease. During surgical
preparation, veins are routinely pressure distended to overcome vasospasm and twists. Distention, however, is believed to
promote vascular remodeling and contribute to decreased graft patency. Pharmacologic vasorelaxation with a combina-
tion of effective vasodilators has been suggested as an alternative to pressure distention. The extracellular matrix
(ECM)-degrading matrix metalloproteinases (MMPs) have been implicated in vascular remodeling and neointima
formation. The purpose of the present study was to compare the effects of pressure distention with pharmacologic
vasorelaxation on graft remodeling and regulation of MMP-2 and MMP-9 in porcine vein grafts.
Methods:Carotid artery bypass utilizing internal jugular veins was performed in eight female white pigs. Jugular veins were
randomized to receive pressure distention (300mmHg for 2 minutes) or a combination of vasodilators (the -adrenergic
antagonist phenoxybenzamine, 10 mol/L; the Rho-kinase inhibitor HA-1077 [fasudil], 50 mol/L; and the calcium-
channel blocker nicardipine, 1 mol/L) for 30 minutes and then were grafted into the carotid arteries. Two weeks after
surgery, vein graft samples were analyzed for vessel intimal and medial area, lumen diameter, and ECM composition.
Molecular analysis using reverse transcription-polymerase chain reaction, Western immunoblotting, gelatin zymography,
and reverse zymography were performed to study the expression and activation of MMP-2 and MMP-9, and tissue
inhibitors of MMP (TIMP)-1 and TIMP-2.
Results: Pressure distention irreversibly overstretched the porcine jugular vein and increased MMP-2 and MMP-9
proteolytic activity by 40% and 77%, respectively. Twoweeks of vein grafting in the carotid arterial bed induced vessel wall
thickening, ECMmodification, and neointima formation, which were more pronounced in the distended grafts (P< .05)
and accompanied by an increase in MMP expression and activity. Distended grafts demonstrated higher percentages of
active MMP-9 (17.8% 1.0%) and higher activities of latent (35.5% 3.3%) and active MMP-2 (69.6% 8.8%) than the
pharmacologically treated grafts. Protein expression of TIMP-1 and TIMP-2 was downregulated after arterial grafting, but
the pharmacologically treated grafts expressed significantlymore TIMP-1 protein (by 36.8% 4.1%) than the distended ones.
The activities of TIMPs were markedly decreased after grafting, contributing to the upregulated MMP activity.
Conclusions: Pressure distention of vein grafts before implantation, compared with pharmacologic vasodilatation,
stimulates neointima formation and augments MMP activities. Pharmacologic vasorelaxation may be clinically superior
to distention in attenuating graft remodeling and possibly improving graft patency. (J Vasc Surg 2005;42:747-56.)
Clinical Relevance: Autogenous vein bypasses are a common and effective method to treat occlusive disease. This study
demonstrated that pressure distention, a common preparatory procedure in bypass surgery, upregulates extracellular
matrix-degrading matrix metalloproteinases, which predisposes vein grafts to extensive remodeling and contributes to
neointima formation and graft occlusion. The topical application of a combination of vasodilators to the vein graft before
implantation may be clinically superior to pressure distention in attenuating graft remodeling and may possibly improve
graft patency and reduce secondary surgical interventions.Arterial reconstruction with autologous tissue by using
vein grafts is an effective and durable treatment for periph-
eral artery occlusion.1-3 During preparation for grafting,
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vasomotor dysfunction,6,7 exaggerated platelet and leuko-
cyte adhesion,8 reduced adenosine triphosphate levels,9
and impaired production of nitric oxide and prostacy-
clin,10,11 the biologic mediators that suppress thrombosis
and atherosclerotic transformation.
Surgical preparation of human saphenous vein, includ-
ing manual distention, induces dedifferentiation of smooth
muscle cells (SMCs), which is characterized by a shifting
from the contractile to the synthetic phenotype.12 Distention-
stimulated SMC proliferation and migration are the major
causes of graft wall thickening and neointima formation.4,5
These processes require coordinated alterations in mito-
genic signaling and the degradation and reorganization of
extracellular matrix (ECM) by matrix metalloproteinases
(MMPs). Proliferation and migration of SMCs have been
shown to be closely related to stimulation of MMPs.13,14
MMP-2 and MMP-9 (gelatinase A and B, respectively) are
especially important regulators of vein graft architecture
because of their specificity for elastin and collagen.15
Mechanical stretch and vascular injury are known to
activate these MMPs and are associated with SMC migra-
tion and vascular remodeling.13,16-20 Secretion, proteolytic
activity, and immuno-positive staining of MMP-2 and
MMP-9 have been shown to be upregulated in porcine vein
grafts.20 MMP activity is tightly controlled at the level of
gene transcription, activation of latent enzyme, and
inhibition by endogenous tissue inhibitors of MMPs
(TIMPs).13,15,21 Therefore, activation of MMPs and a shift
in the balance of the MMP/TIMP system stimulated by
pressure distention could contribute to SMC proliferation
and migration, thus accelerating graft occlusion.
Unfortunately, because human saphenous vein is
highly susceptible to vasoconstriction,7 pressure distension
during surgical preparation for grafting cannot be avoided
without an alternative procedure to prevent vasospasm. We
have previously suggested such an alternative strategy7
based on the topical application of a combination of long-
lasting vasodilatatory agents to the vein before grafting.
This maneuver provides prolonged relief from vasospasm,
which is effective for the critical time period during and
after surgery until established arterial blood pressure pre-
vents vasospasm in the grafted vein.
In the present study, we compared the effects of disten-
tion with pharmacologic treatment on the activity of
MMPs and ECM integrity in the porcine jugular vein
before and after grafting into the carotid artery. For phar-
macologic treatment, vein grafts were exposed to a combi-
nation of vasodilatatory drugs: the -adrenergic antagonist
phenoxybenzamine, the Rho-kinase inhibitor HA-1077
(fasudil), and the calcium-channel blocker nicardipine. To-
gether, these drugs block the main mechanisms of vasocon-
striction in human vessels.7 We hypothesized that pressure
distention upregulates MMP activity and enhances neoin-
tima development during grafting and that pharmacologic
relaxation is beneficial for preserving ECM integrity and
attenuating graft remodeling.METHODS
Animal surgical procedures. All animal procedures
were approved by the University of British Columbia Ani-
mal Ethics Board. Animals were cared in accordance with
the Guide for the Care and Use of Laboratory Animals
published by the United States National Institutes of
Health (NIH Publication No. 85-23, revised 1996). Re-
versed vein grafts utilizing jugular veins were grafted into
the carotid arteries of eight female white pigs that weighed
60 to 65 kg. Pigs were given a general anesthetic (a single
dose of ketamine, 800 to 1400 mg), and under sterile
conditions, a midline neck incision was made to expose
both common carotid arteries and internal jugular veins.
After dissection, veins were removed, reversed, and
randomized to pressure distension or immersion into a
vasodilatatory solution. Veins allocated to pressure disten-
tion were distended with isotonic heparinized saline solu-
tion at 300 mm Hg for 2 minutes. A piece of the distended
vein was taken as a sample. For vein grafts allocated to
immersion, a piece of the vein was taken as the nondistended
sample, and the rest of the vein was placed in a bath containing
a combination of vasodilatatory drugs (phenoxybenzamine,
10 mol/L; HA-1077 (fasudil), 50 mol/L; nicardipine, 1
mol/L)7in a heparinized (1:250 concentration) isotonic
saline solution at room temperature for 30 minutes. An end-
to-end anastomotic technique was used to graft the veins to
the divided carotid artery as an interposition vein graft.
After 2 weeks, the seven pigs that survived the surgery
were given another general anesthetic, and the interposi-
tion vein grafts were removed. All animals were then eutha-
nized. Schemes of experimental design and sampling han-
dling are presented in Appendix Figs E1 and E2 (online
only).
Histology. Vessel segments were formalin fixed, em-
bedded in paraffin, and 3-m cross-sections were prepared
and stained with modified Movat pentachrome. Image
acquisition and processing was performed by using a Mi-
croPhot microscope (Nikon Inc, Kanagawa, Japan.). Images
were captured by a SPOT digital camera (Diagnostic Instru-
ments, Sterling Heights, Mich), and analyzed with ImagePro-
Plus5 software (Media Cybernetics, Silver Spring, Md) (Ap-
pendix, online only).
Reverse transcription-polymerase chain reaction.
Total RNA and protein was extracted from flash-frozen
samples of vessels by TRIzol reagent according to the
manufacturer’s instructions (Invitrogen Life Technologies,
Carlsbad, Calif). Total RNA (1 g) was reverse-transcribed
into complementary DNA (cDNA) using Moloney murine
leukemia virus reverse transcriptase (Invitrogen Life Tech-
nologies). Reverse transcription was performed in a Gene
Amp thermocycle (Gene Amp PCR System 9700, Applied
Biosystems, Foster City, Calif) for 60 minutes at 37°C,
then for 15 minutes at 70°C. First-strand cDNA (5L) was
used for polymerase chain reaction (PCR) as previously
described (Appendix, online only).
Western immunoblotting. Measurement of MMP
expression by Western immunoblotting was previously de-
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separated on 8% (for MMP-2 and MMP-9) or 12% (for
TIMP-1 and TIMP-2) sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) and then trans-
ferred to polyvinyldifluoride membranes (Bio-Rad Labora-
tories, Hercules, Calif). Membranes were first incubated
with primary antibodies: mouse monoclonal anti-MMP-2,
anti-MMP-9 (dilution 1:250) (Oncogene Science, San Di-
ego, Calif) and anti-TIMP-1 or anti-TIMP-2 (dilution
1:400) (Calbiochem, San Diego, Calif) antibodies, and
then with immunoglobulin G peroxidase-conjugated sec-
ondary antibodies (dilution 1:2500). Immunoreactive pro-
teins were visualized by an enhanced chemiluminescence
kit (Amersham Life Sciences, Buckinghamshire, England).
To normalize the protein level, membranes were stripped
and reprobed with -actin antibody.
Gelatin zymography. Gelatinolytic activity of MMPs
was measured as previously described.22 Briefly, protein
extract (2 g) was electrophoresed in 8% SDS-PAGE co-
polymerized with gelatin (2 mg/mL). Gels were washed
with 2.5% Triton X-100, then the enzymatic activity was
developed by incubating the gels in enzyme assay buffer at
37°C for 48 hours. Gels were then stained and destained,
and the gelatinolytic activities were identified as transparent
bands against the blue background. Images were captured
by digital camera (Olympus Optical Co, Tokyo, Japan).
Reverse zymography. Activities of TIMP-1 and
TIMP-2 in tissue extract (2 g) were determined by elec-
trophoresis in 12% SDS-PAGE copolymerized with
1 mg/mL gelatin and 50 ng/mL human recombinant
MMP-2 or MMP-9 (Calbiochem). Gels were rinsed in
2.5% Triton X-100 and then incubated in the enzyme assay
buffer. After staining and destaining the gels, the TIMP
activity was visualized as dark bands against the clear back-
ground.
Materials. All other reagents were the highest molec-
ular grade purchased from Sigma (St Louis, Mo), unless
specifically stated in the text.
Statistics. Data were reported as a mean  standard
error from five to eight independent experiments. A paired
t test was performed to compare the differences between
the two groups. A value of P  .05 was considered signif-
icant.
RESULTS
Vessel morphology and ECM composition.
Pressure distension of 300 mm Hg irreversibly overstretched
the veins, resulting in a 104% 2% increase in lumen diame-
ter-to-thickness ratio (Fig 1, A and B; Appendix Fig E3,
online only) and a reduction of intimal-medial thickness (Ap-
pendix Fig E4, online only). In native veins, elastin was
presented as continuous bands; in distended vessels, it ap-
peared as discontinuous fragments (Fig 1, C and D).
After 2 weeks of implantation, arterial hemodynamics
had a pronounced impact on proliferative and synthetic
processes in the grafts, resulting in wall thickening and
neointima formation (Fig 1, E and F; Fig 2, A; Appendix
Figs E3 and E4, online only). The pressure-distended graftin one of the seven pigs was completely occluded (Fig 1,
H), and one was critically narrowed, whereas all the phar-
macologically treated grafts had clear lumens.
There was no detectable intima between endothelial
and medial layers before grafting, but after grafting, a
profuse neointima had developed. In pressure-distended
grafts, the ratio of intima to media area was 112%  9%
higher than in vein grafts treated with vasodilatators (Fig 2,
A). The neointima consisted of radially oriented proteogly-
can fibers and SMCs (Appendix, online only).
Collagen and elastin composed about 60% and 17% of the
jugular vein body, respectively (Fig 2, B). In the pressure-
distended grafts, significant reductions in the proportions of
elastin (by 49.1% 1.5%) and collagen (by 30.7% 2.0%)
were observed. These changes were less pronounced (P 
.05) in pharmacologically treated grafts. A significant in-
crease in proteoglycans (by 350%  26% in the drug-
treated grafts and by 148  15% in the distended grafts),
which compose about half of the total neointima area, was
evident in both grafts (Fig 1, G; Fig 2, B).
Expression and activity of MMPs. The expression
and activities of MMPs were measured because MMP degra-
dation of ECM can facilitate SMC proliferation and migration
as well as enhance wall thickening and neointima develop-
ment. Distention did not induce immediate changes in gene
transcription or apparent protein expression of MMP-2 or
MMP-9, but 2 weeks of grafting dramatically upregulated
transcription of MMP-2 in both drug-treated and pressure-
distended grafts (by 209%  13% and 149%  14%, respec-
tively) but not of MMP-9 (Fig 3, A).
Western blotting detected two immunoreactive bands
for MMP-2 and MMP-9: 68 kDa-(latent MMP-2), 62
kDa-(active MMP-2), 92 kDa-(latent-MMP-9), and 83
kDa-(active MMP-9) (Fig 3, B). Grafting roughly doubled
the percentage of active MMP-2 in both types of grafts.
The proportion of active MMP-9 increased by 27.7% 
1.3% in the distended grafts, being significantly higher than
that in the drug-treated grafts. The expression of latent
forms of both MMP-2 and MMP-9 was not significantly
altered by grafting and distention (Fig 3, B).
The protein levels of MMP-1 and MMP-3 were also
measured in this study, but their expression was very low
and was not altered by distention and arterial grafting (data
not shown).
In contrast to MMP expression, the activity of the
proteinases was acutely affected by distention of the vein.
Gelatinolytic activity of both MMPs was low in the nondis-
tended veins (Fig 4, zymogram); however, distention in-
stantly upregulated the activities of latent MMP-9 by 39.9%
2%, latent MMP-2 by 77.1%  6.6%, and active MMP-2 by
187% 4% (Fig 4, bar graphs).
Arterial grafting caused further activation of both
MMPs. In the distended grafts, activities of latent and
active forms of MMP-2 were 35.5% and 69.6%, respec-
tively, higher than the drug-treated grafts (Fig 4, lower bar
graph). Although the latent MMP-9 activity was about
doubled in two postgrafts (Fig 4, upper bar graph), we did
not detect changes in the activity of active MMP-9
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intensity of the bands.
Regulation on the endogenous inhibitory system of
MMPs-TIMPs. TIMPs represent one of the mechanisms
regulating MMP activity. The most abundant TIMPs
present in vascular tissue are TIMP-1 and TIMP-2.13,21
Their transcription was low in the intact veins and was not
altered by distention and arterial grafting (Fig 5, A);
whereas protein levels were markedly downregulated after
arterial grafting (Fig 5, B). However, TIMP-1 protein
levels in the pharmacologically treated grafts were signifi-
Fig 1. Representative Movat stained photomicrograph
magnification; (E and F) pharmacologically treated and
matrix composition; and (H) occluded distended graft
collagen, yellow; and proteoglycan, green. Smooth musc
samples from five to eight independent experiments.cantly higher (by 36.8%  4.1%) than those in distendedgrafts. No difference was seen in the level of TIMP-2. The
activities of both TIMP-1 and TIMP-2 were markedly
suppressed after grafting, but there was no difference be-
tween the two postgrafts (Fig 5, C).
DISCUSSION
The present study describes the effects of pressure
distention, compared with a vasodilatory cocktail, and ar-
terial hemodynamics on vascular remodeling and MMP
activities in a porcine vein graft model. We showed that
pressure distension of the vein enhanced the degree of
o D, Nondistended and distended veins with different
ended grafts; (G) area with representative extracellular
The extracellular matrix components are elastin, black;
ls are purple. Arrows indicate neointima. Representatives. A t
dist
. G,
le celgrafting-induced wall thickening and neointima formation
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remodeling is associated with elevated activities of MMP-2
and MMP-9 and modification of ECM and could account
for the early venous graft occlusion.
Grafting of veins in the arterial bed is known to induce
wall thickening and intimal hyperplasia, leading to graft ste-
nosis.4,5 The main cause for this is high and pulsatile blood
pressure in the arterial circulation to which the vein was not
exposed in its original location concomitant with increased
production of cytokines and growth factors. High and pulsa-
tile pressure stimulates SMC proliferation and ECM produc-
tion for the adaptation of grafts to the arterial circulation.4,5
Some conditions during surgery, such as pressure distention
together with ischemia and increased cytokine secretion, ex-
Fig 2. Morphometric analysis and extracellular matrix c
stained cross-sections. A, Shows ratio of intima area to m
proteoglycan, and collagen. *P  .05, n  5 to 8.acerbate these processes and accelerate graft failure. Each ofthese conditions could be a target for improving vein graft
patency, especially distension, which is usually done with
pressures exceeding arterial pressure.
Unlike ischemia and cytokine production, which are due
to surgical trauma, distention can be avoided in the surgical
preparation of the vein for grafting. The current technique of
vein graft preparation requires distention of the vein to over-
come vasospasm; however, an alternative procedure could be
adopted to prevent vasospasm during and after surgery. We
have suggested such an alternative procedure7 that is based on
the topical application of vasodilatators to the vein before
grafting (Appendix, online only).
In the present study, we investigated the effects of
distention, compared with pharmacologic treatment, on
sition of vein and graft segments measured from Movat
area. B, Bar graph presents the percent area of elastin,ompo
ediapig jugular veins before grafting and after a 2-week implan-
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tion of MMPs. We found the short-term impact of disten-
tion had persistent effects, such as overstretching of the vein
(Fig 1, A and B; Appendix Fig E3 and E4, online only) and
disruption of the elastin fibril structure (Fig 1, C and D).
The arterial hemodynamics during 2 weeks of grafting
resulted in striking changes in structure and composition of
the vein segments. The thickness of the intimal-medial layer
was increased several times, and a profuse neointima was
developed. Proteoglycans, practically absent in veins, be-
came abundant in grafts, especially in the neointima.
Nevertheless, 2 weeks of exposure to the arterial circu-
lation did not mask the damaging effect caused by pressure
distention. The distended grafts had a higher degree of
vessel wall thickening. The ratio of intima-to-media area
was higher in the distended grafts, which also demonstrated
more modifications in ECM composition than the drug-
treated grafts. The neointima mainly consisted of radially
oriented proteoglycan fibers and SMCs. Proliferation and
migration of medial SMCs to neointima requires the loos-
ening of the ECM around cells. An increase in the proteo-
lytic activity of MMPs, resulting in degradation of ECM,
could facilitate SMC migration and proliferation. Indeed,
we found MMP activation was associated with distention.
We showed that the activities of both MMP-2 and
MMP-9 increased markedly after distention. This is the first
report of acute activation of MMP by distention in vein
grafts. The instantaneous increase in MMPs activities, in-
duced by distention (Fig 4), suggested that pressure disten-
Fig 3. MMP-2 and MMP-9 gene transcription and p
distention or drug treatment. A, Representative polym
MMP-2, MMP-9 and -actin (loading control). Densito
loading control). B, Bar graphs show the percentage
expression (active  latent form) from 10 g of sample
immunoblots of the MMP-related immunoreactivity det
to 8. MMP, Matrix metalloproteinase.tion triggers cellular responses. Two weeks of graftingaugmented MMP-9 activity in both types of graft, but a
greater increase in MMP-2 activity was observed in the
distended grafts than in the drug-treated ones. The activi-
ties of both forms of MMP-2 remained higher in the
distended grafts than in those pharmacologically treated.
We can therefore suggest that the MMP activation stimu-
lated by distention, which remains increased during graft-
ing, contributes to more pronounced graft remodeling.
MMP-2 and MMP-9 have both been implicated in
atherosclerosis and restenosis13,15-19 as well as neointima
formation in human saphenous vein in organ culture.23,24
Increased secretion of MMP-2 and MMP-9 in a pig venous
graft model has been shown,20 and activation of these
MMPs was demonstrated in human saphenous vein after
surgical preparation that included manual distention.25
However in the these experiments, in contrast to our
design, the effect of distention on MMP activity could not
be segregated from the effects of prolonged ischemia and
other surgical procedures.
The initial response to MMP activation could be medi-
ated through integrins,26 which serve as a transmembrane
link between the ECM and intracellular signaling and thus
could be first affected by distention. Several mechanisms
regulate MMP activity: gene transcription, levels of endog-
enous TIMPs, and activation of the latent enzyme.13,15,21
In this study, we showed that arterial grafting upregulated
MMP-2 at both messenger RNA (mRNA) and protein
levels, while MMP-9 expression was increased only at pro-
tein levels, suggesting a differential regulation of these
expression in veins and grafts subjected to pressure-
chain reaction images show the gene transcription of
c measurement of MMP-2 transcript (normalized to the
tive MMP-2 and MMP-9 relative to the total protein
ein extract. Insets, Representative loading control and
ed from Western blotting. *P .05, paired t test; n 7rotein
erase
metri
of ac
prot
erminMMPs after grafting. Factors leading to remodeling and
. *P
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tion and hemodynamic forces, have been suggested to
induce MMP expression.13,20,25
TIMPs control MMP activity by inhibiting the active
forms of MMPs directly and by inhibiting the transition of
the proenzymes into the active form.21 Additionally,
TIMP-2 has been shown to regulate MMP-2 activity in a
biphasic manner dependent on the stoichiometric ratio of
TIMP-2 to pro-MMP-2. High concentrations of TIMP-2
Fig 4. Proteolytic activities of MMP-2 and MMP-9 i
treatment. Protein extract (2 g) was electrophoresed in
copolymerized with gelatin (2 mg/mL). Gelatinolytic a
background. Representative zymogram (inset) shows ac
latent MMP-2 (68 kDa), and active MMP-2 (62 kDa
activities of latent MMP-9 and latent and active MMP-2inhibit MMP-2 activity, but a low level of TIMP-2 actuallyactivates pro-MMP-2 in the cell surface MMP-14/TIMP-
2/pro-MMP-2 trimeric complex.27
We showed decreased levels of TIMPs after grafting,
which could contribute to the higher levels of MMP activ-
ities in the graft (Figs 4 and 5). Drug-prepared grafts
expressed a significantly higher level of TIMP-1 protein
(36.8%  4.1%) compared with distended grafts. A similar
result was not observed with TIMP-2. This might be
explained by the effects of peroxynitrite, which is generated
s and grafts subjected to pressure distention or drug
dium dodecyl sulfate-polyacrylamide gel electrophoresis
es were identified as transparent bands against the blue
s of latent MMP-9 (92 kDa), active MMP-9 (83 kDa),
e densitometric measurement (bar graphs) shows the
 .05, n  5 to 8. MMP, Matrix metalloproteinase.n vein
8% so
ctiviti
tivitie
). Thduring distention and grafting28 and degrades TIMP-129.
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inhibitory capability against MMP-9,13,21 is consistent with
less expression of the active MMP-9 in the drug-treated
grafts than in distended grafts (Fig 3, B; Fig 5). However,
the activity of latent MMP-9 from both postgrafts was not
substantially different (Fig 4). The equal reduction in
TIMP-2 in both grafts, which has a higher affinity for
MMP-2,13,21 correlates with the same increased level of
active MMP-2 expression after grafting (Fig 3, B; Fig 5).
Nevertheless, alterations in TIMPs could not explain
the significant difference in the activity of MMP-2 observed
Fig 5. TIMP-1 and TIMP-2 gene transcription, prote
pressure distention and drug treatment. A, Representati
of TIMPs. B, Bar graphs represent the densitometric me
Representative immunoblots (insets) show the TIMP-rel
shows activity of TIMPs, which was visualized as dark ba
Tissue inhibitor of matrix metalloproteinases.between distended and drug-treated veins and grafts (Fig4), without significant changes in their protein levels (Fig 3,
B). These discrepancies raise the possibility that additional
mechanisms regulate MMP activity related to the activation
of latent proteinases. MMPs are secreted as proenzymes in
which the prodomain shields the catalytic site by a thiol
linkage. The proenzyme transforms into the active form by
the cleavage of the prodomain or the disruption of the thiol
linkage, which leads to autoactivation.30
It has been shown in SMCs that reactive oxygen species
(ROS) and peroxynitrite, the product of their reaction with
nitric oxide, react with thiol groups and stimulate the
pression, and activity in veins and grafts subjected to
lymerase chain reaction images show gene transcription
ment of TIMPs expression in 10 g of sample protein.
mmunoreactivity. C, A representative reverse zymogram
gainst a clear background. *P  .05, n  5 to 8. TIMP,in ex
ve po
asure
ated i
nds atransition to active forms.31 ROS may be increased within
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oxide production has been demonstrated in vein-carotid
artery bypass grafting.28 Increased MMP expression and
activity under cyclic mechanical stretch in a mouse model is
dependent on ROS production.32 The activation of MMPs
by ROS/peroxynitrite could therefore participate in the
pathogenesis of distention and grafting of the veins. How-
ever, peroxynitrite causes tyrosine nitration, which is ac-
companied by decreased immunosensitivity of MMPs to
their antibodies,31 and consequently decreased the corre-
sponding band in Western blotting. Thus, the discrepancy
between MMP activation after distention revealed by zy-
mography (Fig 4) and the protein expression (Fig 3, B)
could be explained by tyrosine nitration of the MMP due to
the increased ROS level, which reduces immunosensitivity
of the MMP.
Although we believe that most of the differences be-
tween the distended and pharmacologically treated grafts
are contributed by the detrimental effects of distention, we
cannot rule out the possible beneficial effects of the appli-
cation of vasodilators before grafting. Vessels were exposed
to drugs only for 30
least 24 hours after the drugs were removed.7 This period
minutes, but the effect lasted for at
of time was crucial for the vessels, as the absence of circu-
lation during surgery causes hypoxia and accumulation of
cytokines that leads to extensive proliferative and inflam-
matory responses.
The drugs in the pharmacologic combination we used
are known not only as vasodilators but also as regulators of
inflammation and proliferation. Fasudil is effective in sup-
pressing vascular remodeling and reducing intimal hyper-
plasia through inhibiting migration and proliferation of
SMCs and enhancing cell apoptosis.33 Nicardipine treat-
ment in a rabbit venous graft model resulted in reduction of
intimal and medial thickness.34 A role for -adrenergic
stimulation in DNA synthesis and SMC proliferation has
also been suggested.35 It is therefore possible that the drug
treatment by itself contributed to the reduction of vascular
remodeling and neointima formation in the vein grafts.
CONCLUSION
We demonstrated that pressure distention and arterial
hemodynamics synergistically affect ECM integrity and
vascular remodeling in vein grafts. Compared with pharma-
cologic relaxation of veins during preparation for grafting,
pressure distension accelerated vessel wall thickening, neo-
intima development, and modification of ECM composi-
tion. This vascular remodeling is associated with the ele-
vated activities of MMP-2 and MMP-9 induced by
distention.
The increase in MMP activities was observed even after
a 2-week implantation of the distended grafts and could in
part be responsible for the detrimental effects of pressure
distention compared with pharmacologic vasorelaxation.
Appropriate pharmacologic treatment of the vein during
surgical preparation with a combination of vasodilatatory
agents could therefore be an alternative to damaging pres-
sure distention, not only to overcome vasospasm but also topreserve vein grafts before implantation, attenuate graft
remodeling, and eventually prolong graft patency.
We greatly appreciate the help of Hongbin Zhang, a
statistician of St Paul’s Hospital, with the statistical analysis.
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